- Home
- IBP vs ICUI Comparison
IBP vs ICUI Comparison
Compare IBP & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBP
- ICUI
- Stock Information
- Founded
- IBP 1977
- ICUI 1984
- Country
- IBP United States
- ICUI United States
- Employees
- IBP N/A
- ICUI N/A
- Industry
- IBP Homebuilding
- ICUI Medical/Dental Instruments
- Sector
- IBP Consumer Discretionary
- ICUI Health Care
- Exchange
- IBP Nasdaq
- ICUI Nasdaq
- Market Cap
- IBP 4.5B
- ICUI 3.6B
- IPO Year
- IBP 2014
- ICUI 1992
- Fundamental
- Price
- IBP $168.68
- ICUI $135.66
- Analyst Decision
- IBP Buy
- ICUI Buy
- Analyst Count
- IBP 11
- ICUI 5
- Target Price
- IBP $226.00
- ICUI $197.50
- AVG Volume (30 Days)
- IBP 415.9K
- ICUI 339.0K
- Earning Date
- IBP 05-08-2025
- ICUI 05-08-2025
- Dividend Yield
- IBP 1.85%
- ICUI N/A
- EPS Growth
- IBP 5.69
- ICUI N/A
- EPS
- IBP 9.10
- ICUI N/A
- Revenue
- IBP $2,941,300,000.00
- ICUI $2,382,046,000.00
- Revenue This Year
- IBP N/A
- ICUI $0.84
- Revenue Next Year
- IBP $4.57
- ICUI $2.91
- P/E Ratio
- IBP $18.54
- ICUI N/A
- Revenue Growth
- IBP 5.86
- ICUI 5.44
- 52 Week Low
- IBP $151.27
- ICUI $94.19
- 52 Week High
- IBP $281.04
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- IBP 50.89
- ICUI 44.75
- Support Level
- IBP $162.69
- ICUI $126.00
- Resistance Level
- IBP $175.67
- ICUI $139.12
- Average True Range (ATR)
- IBP 10.25
- ICUI 8.92
- MACD
- IBP 0.64
- ICUI -0.23
- Stochastic Oscillator
- IBP 53.10
- ICUI 36.56
About IBP Installed Building Products Inc.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.